Philips Medical Systems has formally rolled out Gyroscan CV, the vendor’s cardiovascular MRI system. Initially highlighted at the 1998 RSNA meeting (SCAN Special Report 1/99), Gyroscan CV employs a 1.5-tesla open magnet design and features
Philips Medical Systems has formally rolled out Gyroscan CV, the vendors cardiovascular MRI system. Initially highlighted at the 1998 RSNA meeting (SCAN Special Report 1/99), Gyroscan CV employs a 1.5-tesla open magnet design and features optimized cardiovascular software, a five-element cardiac coil, and the firms EasyVision diagnostic workstation.
Gyroscan CV can provide information about cardiac anatomy and pathology; ventricular function; valvular function; wall motion, wall thickness, and thickening; myocardial perfusion; and coronary angiography, according to Philips of Best, The Netherlands. Philips believes that by using Gyroscan CV, healthcare institutions can reduce the need for x-ray and nuclear medicine scans, as well as contrast media.
One of the available options on Gyroscan CV is MobiTrak, an automated peripheral vascular angiography tool. MobiTrak, first shown at the 1996 RSNA meeting, combines contrast-enhanced 3-D MR angiography (MRA) with rapid, automatic table movement between successive coronal acquisitions. The result is high quality images from the abdominal aorta to the feet with a scan time of three to four minutes, according to Philips.
Another MRA technique, BolusTrak, provides real-time display and visual detection for contrast-enhanced procedures. With BolusTrak, the angiography acquisition can be precisely synchronized to the arrival of the bolus, according to Philips.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.